Obesity and oesophageal function: from reflux to dysphagia

The impact of obesity on esophageal function and disease reaches beyond heartburn. Excess adiposity can alter lower oesophageal sphincter function, increase reflux exposure and contribute to swallowing difficulty, while chronic inflammation may affect the lining of the oesophagus. These relationships are clinically important, although they vary between people and do not make severe disease inevitable.

The 17th World Congress for Esophageal Diseases, held virtually from 27–30 September 2021, brought together research and clinical sessions focused on oesophageal health and disease. The official ISDE 2021 congress website provides the scientific programme, abstracts and information about the International Society for Diseases of the Esophagus, giving the discussion of obesity and oesophageal outcomes a wider specialist context.

Why excess weight changes oesophageal mechanics

Greater visceral fat and higher intra-abdominal pressure can raise pressure at the lower oesophageal sphincter and weaken the seal between the stomach and oesophagus. The diaphragm and crura may also change in ways that favour a hiatal hernia. Together, these shifts can increase the frequency of reflux events and extend the time that acidic or non-acid material remains in the oesophageal lumen.

Adipose tissue is also an active source of inflammatory signals. Hormones such as leptin and adipokines may influence oesophageal sensation, smooth-muscle function and gastric emptying. Some studies find impaired motility or reduced clearance in people with obesity, but results are not uniform; symptoms should therefore be assessed rather than attributed to body size alone.

Reflux, Barrett's oesophagus and cancer risk

Reflux is the clearest oesophageal association. Obesity is associated with symptomatic gastro-oesophageal reflux, frequent regurgitation and erosive oesophagitis. Night-time symptoms may be amplified by poor sleep, while larger meals and longer periods lying down can increase pressure and reflux burden. Dietary measures and positional strategies can help, but persistent symptoms deserve formal assessment.

Chronic reflux can lead to Barrett's oesophagus, in which the normal lining changes in response to injury. Obesity is associated with increased odds of Barrett's and oesophageal adenocarcinoma, yet the strength of this relationship differs by study and is partly explained by reflux severity. Diagnosis still requires endoscopy and biopsy; symptoms alone cannot identify Barrett's or exclude dysplasia.

Swallowing difficulty and motility disorders

Dysphagia may arise from structural narrowing, inflammation, impaired muscular coordination or simply the sensation that food is sticking. Obesity can be associated with hypercontractile or poorly contracting oesophageal muscles, and reflux-related strictures may create genuine obstruction. New-onset progressive dysphagia, food impaction or weight loss is an alarm pattern rather than a routine consequence of obesity.

Bariatric procedures further complicate the picture. Sleeve gastrectomy can be followed by narrowing or altered motility, while Roux-en-Y gastric bypass often reduces reflux but may create anastomotic or motility symptoms. Pre-operative assessment may therefore include upper endoscopy and, when indicated, oesophageal manometry. Dietitians and speech pathologists can help with texture, meal pacing and nutritional adequacy.

Eosinophilic oesophagitis and immune-mediated disease

Eosinophilic oesophagitis is another inflammatory condition linked with obesity in population studies. Both can involve type 2 immune pathways, and symptoms may overlap: heartburn, regurgitation, chest discomfort and difficulty swallowing. The association does not prove that excess weight causes eosinophilic oesophagitis, and losing weight cannot replace diagnostic evaluation or anti-inflammatory treatment.

Diagnosis still depends on endoscopy with oesophageal biopsies, usually after appropriate withholding of proton-pump inhibitors under specialist guidance. Empiric elimination diets can work in selected patients, but dietitian supervision is important in Australia to avoid nutritional deficiencies, especially in children and in people with restricted eating. Steroid or other immune-directed therapy may be needed when diet is ineffective or unsuitable.

Australian food markets, cities and healthcare access

Australian food environments shape the exposure. Everyday supermarkets such as Coles and Woolworths carry high-energy, high-salt convenience foods alongside fresh produce, while frequent takeaway dining in Sydney, Melbourne, Brisbane and other cities makes large, rapidly eaten meals common. Around three in ten Australian adults live with obesity, so clinicians often face metabolic, sleep and oesophageal symptoms in the same patient rather than isolated reflux.

Access is uneven. People in rural and remote communities may live far from endoscopy and motility services, although Medicare-funded telehealth can support initial review and remote follow-up. Public hospital waiting times and limited specialist capacity can delay investigation. Culturally safe care, interpreter access and involvement of Aboriginal and Torres Strait Islander health services are essential when symptoms, food security and treatment preferences shape the plan.

Diagnosis, treatment and coordinated risk reduction

Assessment should establish symptom pattern, medications, diet, weight trajectory, smoking and alcohol use, and any alarm features. Acid suppression may be appropriate for reflux, while weight management, meal timing and sleep interventions address contributors. For Barrett's oesophagus, surveillance follows established guidelines; endoscopic therapy may be considered for dysplasia under specialist supervision.

Evidence-based obesity treatment may improve reflux and metabolic health, but the oesophageal diagnosis still needs its own pathway. In Australia, Medicare subsidises bariatric services for eligible patients through the public system, and multidisciplinary care commonly includes a GP, gastroenterologist, dietitian and psychologist. Endoscopic therapy can treat selected precancerous Barrett's lesions, while anti-reflux and motility care should be tailored to the confirmed problem.

For someone with persistent reflux, recurrent food impaction or progressive swallowing difficulty, the next step is to book a GP review that explicitly includes oesophageal symptoms, record the pattern and request gastroenterology assessment when indicated.